Articles

Podcasts

Videos

Geriatrics

Geriatric medicine condition center page is a comprehensive resource for clinical news and insights on frequent geriatric-related diseases and conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for sleep disorder, dementia, Alzheimer's disease, and more.

Brent Forester, MD, MSc, discusses the confluence of biomarker and disease-targeting therapy in Alzheimer's, and the need to appropriately introduce these tools.

Blood Biomarkers, Aducanumab and Setting Precedent for Dementia Care Advances

Rajesh R. Tampi, MD, MS, discusses the evolved definition of dementia as a cognitive disorder, and how its spectrum of symptoms impact clinical development.

The Developing Dementia Definition, Treatment Field

There remains a need for more doctors that specialize in geriatrics.

Lee Lindquist, MD, MPH: The Many Roles of Geriatricians

The Lumipulse G β-Amyloid Ratio is the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimers disease.

FDA Permits Marketing of New Diagnostic Test for Alzheimers Disease

The investigators generated a list of 250 genes that are known to regulate individual reactions within the component pathways of the Alzheimer Disease Aberrant Metabolism (ADAM) network.

Researchers Look for Potential Treatments for Alzheimer Disease

Researchers examine how biomarkers are differentially mapped to MRI measures of cortical thickness. 

Researchers Clarify Alzheimer Disease Biomarkers and MRI Measures

At the 76-week mark, reductions in the amyloid plaque level were 85.06 centiloids with donanemab than with placebo.

Donanemab Shows Promise as a Alzheimer Disease Treatment

Alector’s announcement about the INVOKE-2 study follows a similar update regarding its INFRONT-3 study for frontotemporal dementia.

Alector Moving Forward with AL002 Alzheimer Disease Trial

The Cassava Sciences agent showed 6-month improvements in both ADAS-Cog and NPI scores, and a phase 3 trial is expected to begin in late 2021.

Simufilam Shows Promise Improving Cognition, Behavior in Alzheimer Disease Patients

Fewer patients who received masitinib 4.5 mg/kg/day reached severe dementia stage.

Masitinib Shows Promise in Alzheimer Disease Study

Alzheimer Disease condition center page, resources on the topics of medical news and expert insight into Alzheimer's can be found. Content includes articles, interviews, videos, podcasts, and breaking news on Alzheimer disease research, treatment, and drug development.

Alzheimer Disease

Latest News